---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-032932"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2026-10-19T20:06:47+00:00"
generated_at: "2026-10-19T20:08:24.003755+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vaxart Appoints Dr. Raquel Bono to Board of Directors

## Summary
- Raquel C. Bono, M.D., retired U.S. Navy Vice Admiral, was appointed to Vaxart's board effective Oct. 16, 2026; the board deemed her independent.
- Bono led the Defense Health Agency from 2015 to 2019, overseeing a $50 billion global healthcare system serving 9.5 million beneficiaries.
- She was appointed under Vaxart's July 2026 cooperation agreement with stockholders and will chair the Stockholder Engagement Committee.
- Bono is a Humana (NYSE: HUM) director and served as Chief Health Officer of Viking Cruises (NYSE: VIK) from November 2020 to December 2023.

## SEC filing metadata
- accession: 0001437749-26-032932
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2026-10-19T20:06:47+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774926032932/0001437749-26-032932-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774926032932/vxrt20261016_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-032932
- JSON: https://secwatch.observer/filing/0001437749-26-032932.json
- Plain text: https://secwatch.observer/filing/0001437749-26-032932.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.